The significance of uric acid in the diagnosis and treatment of Parkinson disease: An updated systemic review.

Abstract

BACKGROUND:

Parkinson disease (PD) is a neurodegenerative disease characterized by chronic and progressive loss of dopaminergic neurons in substansia nigra pars compacta. Oxidative stress is proposed to play a critical role in the pathogenesis of PD. Uric acid (UA), as an important physiological antioxidant, is identified a molecular predictor associated with a decreased risk and a slower disease progression for PD and potential neuroprotectant of PD by increasing epidemiological and clinical evidences. Within this review, we will present a comprehensive overview of the data linking UA to PD in recent years.

METHODS:

We searched PubMed, EMBASE, Web of Science databases for relevant studies. Any observational or experimental studies that evaluated UA and PD were our goal of searching the electric databases.

RESULTS:

Twelve studies that evaluated UA and PD were identified in this review. We reviewed the roles of UA in the pathogenesis of PD, the association of UA with morbidity, severity/progression, nonmotor symptoms, motor complications of PD, with an attempt to provide new ideas for diagnosis and treatment in PD.

CONCLUSION:

Our findings supported that lots of clinical and epidemiological data observed lower UA levels in PD patients. Manipulation of UA or its precursors' concentration could be effective to treat or prevent PD. However, it is still suspectable that higher UA levels are better enough to PD patients. Furthermore, for the complex nature of PD and its heterogeneous genetic and environmental influences, it is inadequate for just manipulating UA in treating the disease.

• Authors: Zhange Yu, Shuai Zhang, Dongdong Wang, Meng Fan, Fuqiang Gao, Wei Sun, Zirong Li, Shiliang Li
• Journal: Medicine (Medicine (Baltimore)) Vol. 96 Issue 45 Pg. e8502 (Nov 2017) ISSN: 1536-5964 [Electronic] United States
• PMID: 29137045 (Publication Type: Journal Article, Meta-Analysis, Review, Systematic Review)

Chemical References

• Biomarkers
• Uric Acid

Topics

• Humans
• Age Factors
• Biomarkers
• Disease Progression
• Hyperuricemia (epidemiology)
• Movement Disorders (blood, physiopathology)
• Oxidative Stress (physiology)
• Parkinson Disease (blood, epidemiology, physiopathology)
• Severity of Illness Index
• Sex Factors
• Uric Acid (blood, metabolism)